$5.66
-0.09 (-1.57%)
CryoLife, Inc. (NYSE:CRY)
CAPS Rating:
The Company develops and commercializes biomaterials, implantable medical devices, and preserves and distributes human tissues for cardiovascular and vascular transplant applications.
RSS Headlines
Fool UK